Health Care & Life Sciences » Biotechnology | Uni-Bio Science Group Ltd.

Uni-Bio Science Group Ltd. | Cash Flow

Fiscal year is January-December. All values HKD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
68,263.00
41,043.00
57,230.00
53,820.00
278,297.00
138,433
Depreciation, Depletion & Amortization
62,047.00
64,143.00
31,715.00
27,847.00
30,256.00
20,920
Other Funds
-
17,498.00
-
-
-
28,572
Funds from Operations
15,344.00
4,220.00
20,321.00
21,572.00
42,331.00
88,941
Changes in Working Capital
12,414.00
51,129.00
1,017.00
1,244.00
25,647.00
772
Net Operating Cash Flow
27,758.00
55,349.00
19,304.00
22,816.00
67,978.00
88,169
Capital Expenditures
25,400.00
20,250.00
33,004.00
20,578.00
26,078.00
Sale of Fixed Assets & Businesses
14.00
1,271.00
463.00
120.00
44.00
Purchase/Sale of Investments
-
158,255.00
8,256.00
-
67,743.00
Net Investing Cash Flow
25,386.00
139,276.00
40,797.00
51,231.00
93,777.00
Issuance/Reduction of Debt, Net
42,613.00
-
9,662.00
1,328.00
11,990.00
Net Financing Cash Flow
42,613.00
1,078.00
38,250.00
16,371.00
129,802.00
Net Change in Cash
8,139.00
81,899.00
28,112.00
62,670.00
24,579.00
Free Cash Flow
51,863.00
72,127.00
38,141.00
35,352.00
92,553.00
Change in Capital Stock
-
18,576.00
28,588.00
15,043.00
141,792.00
Exchange Rate Effect
2,392.00
3,106.00
6,261.00
4,994.00
7,374.00
Other Uses
-
-
-
30,773.00
-

About Uni-Bio Science Group

View Profile
Address
Unit 502, 5/F
Hong Kong
Hong Kong
Employees -
Website http://www.uni-bioscience.com
Updated 07/08/2019
Uni-Bio Science Group Ltd. is an investment holding company with interests in pharmaceutical research and development. It operates through the following segments: Manufacture and Sale of in-house chemical pharmaceutical products; Manufacture and sale of in-house biological pharmaceutical products; Industrialization of in-house biological pipeline; and Third Party pharmaceutical products. The company was founded in 2001 and is headquartered in Hong Kong.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.